Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-02-02 @ 12:26 AM
Study NCT ID:
NCT00523432
Status:
COMPLETED
Last Update Posted:
2013-09-05
First Post:
2007-08-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
Sponsor:
University of Chicago
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Genital Neoplasms, Female | View |